PRESS RELEASE published on 09/17/2025 at 14:00, 7 months 25 days ago Informations privilégiées / Autres communiqués Teva et Medincell présenteront les résultats de phase 3 de l'Olanzapine LAI à Psych Congress 2025, préparant le lancement du traitement de la schizophrénie avec Teva Schizophrénie Phase 3 Medincell Teva Olanzapine LAI
BRIEF published on 09/12/2025 at 07:35, 8 months ago Medincell nomme trois nouveaux membres au conseil d'administration Innovation Biopharmaceutique Direction Nominations Au Conseil D'administration Medincell
BRIEF published on 09/12/2025 at 07:35, 8 months ago Medincell Appoints Three New Board Members Innovation Biopharmaceutical Leadership Board Appointments Medincell
PRESS RELEASE published on 09/12/2025 at 07:30, 8 months ago Informations privilégiées / Autres communiqués Medincell nomme le Dr Sharon Mates, le Dr Charles Kunsch et le Dr Pascal Touchon au conseil d'administration lors de l'AG annuelle et extraordinaire. Contribution cruciale pour l'avenir de l'entreprise Conseil D'administration Medincell Dr Sharon Mates Dr Charles Kunsch Dr Pascal Touchon
PRESS RELEASE published on 09/12/2025 at 07:30, 8 months ago Inside Information / Other news releases Medincell appoints Dr. Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon to its Board of Directors, adding valuable expertise in biotech and pharmaceutical sectors Board Of Directors Medincell Dr. Sharon Mates Dr. Charles Kunsch Dr. Pascal Touchon
BRIEF published on 09/10/2025 at 21:46, 8 months 2 days ago UZEDY® obtient l'approbation en Corée du Sud après son succès aux États-Unis Schizophrénie UZEDY Approvisionnement Médical Teva Handok Marché Coréen
BRIEF published on 09/10/2025 at 21:46, 8 months 2 days ago UZEDY® Obtains Approval in South Korea Following Success in the United States Schizophrenia UZEDY Teva Handok Medical Supply Korean Market
PRESS RELEASE published on 09/10/2025 at 21:41, 8 months 2 days ago Inside Information / Other news releases Teva Handok announces regulatory approval for UZEDY® in South Korea by Ministry of Food and Drug Safety, following successful US launch. Medincell's long-acting injectable for schizophrenia shows strong commercial performance Regulatory Approval Schizophrenia Medincell Commercial Performance Teva Handok
PRESS RELEASE published on 09/10/2025 at 21:41, 8 months 2 days ago Informations privilégiées / Autres communiqués UZEDY(R) approuvé en Corée du Sud après un lancement réussi aux États-Unis. Medincell percevra des royalties sur les ventes et est éligible à des milestones commerciaux Schizophrénie Approbation Medincell Corée Du Sud UZEDY
BRIEF published on 08/04/2025 at 14:05, 9 months 8 days ago Medincell Annonce son Assemblée Générale 2025 Gouvernance Assemblée Générale Resolutions Medincell Rémunérations
Published on 05/12/2026 at 21:55, 52 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 1 hour 5 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 8 hours 17 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 14:30, 8 hours 17 minutes ago ACCESS Newswire Reports First Quarter 2026 Results
Published on 05/12/2026 at 13:50, 8 hours 57 minutes ago Polaris Renewable Energy Announces Approval of SO1 Agreement by FOMB
Published on 05/12/2026 at 22:25, 21 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 2 hours 25 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 3 hours 12 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 3 hours 12 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:46, 4 hours ago LION E-Mobility Reports Q1 Results and Confirms Fiscal 2026 Outlook
Published on 05/12/2026 at 18:15, 4 hours 32 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 4 hours 32 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 4 hours 37 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 4 hours 37 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 4 hours 57 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
